TBPH
Theravance Biopharma Inc
17.00$
+0.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 8.5% | 47.3% | 61.8% | 69.8% | 54.9% | 50.4% | 74.4% | 40.0% | 40.6% | 3.3% | 8.1% | 7.0% | 12.0% | |
| 91.5% | 52.7% | 38.2% | 30.2% | 45.1% | 49.6% | 25.6% | 60.0% | 59.4% | 96.7% | 100.0% | 93.0% | 89.4% | |
| 50.2% | 51.2% | 61.8% | 69.8% | 54.9% | 50.0% | 74.4% | 40.0% | 40.6% | 15.2% | 32.9% | 22.7% | 24.6% | |
| 102.9% | 61.2% | 115.4% | 119.6% | 100.0% | 75.7% | 119.4% | 70.4% | 91.7% | 40.4% | 100.1% | 68.4% | 65.9% | |
| 147.3% | 88.2% | 115.4% | 140.3% | 109.3% | 98.7% | 119.4% | 70.4% | 91.7% | 58.4% | 133.1% | 96.0% | 84.9% | |
| -55.8% | -35.5% | -77.3% | -110.2% | -64.2% | -49.1% | -93.8% | -10.4% | -32.3% | 38.3% | -33.1% | -2.9% | 4.5% | |
| 3.9% | 3.5% | 4.3% | 4.5% | 3.7% | 3.4% | 4.2% | 2.5% | 2.9% | 1.3% | 0.0% | 0.0% | 1.1% | |
| -48.3% | -28.6% | -71.7% | -106.8% | -59.6% | -47.7% | -91.9% | 279.5% | -14.5% | 159.2% | -36.6% | -23.1% | 56.5% | |
| 8.7% | 19.9% | 8.7% | 9.2% | 15.7% | 35.1% | -3.6% | 70.1% | -32.5% | 26.2% | -8.7% | 5.3% | 4.9% | |
| -57.0% | -48.4% | -80.4% | -115.9% | -75.3% | -82.8% | -88.2% | 209.3% | 18.1% | 133.0% | -27.9% | -28.5% | 51.6% | |
| -35.9% | -35.3% | -64.4% | -86.5% | -52.4% | -40.5% | -85.0% | 283.6% | -9.5% | 163.8% | -31.8% | 4.0% | 65.6% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.